NCT04442919View on ClinicalTrials.gov

Influence of METHoxyflurane on ANtiplatelet Effect of Ticagrelor in Patients With Unstable Angina Pectoris

PHASE4CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

January 31, 2024

Study Completion Date

February 29, 2024

Conditions
Unstable Angina
Interventions
DRUG

Ticagrelor followed with Methoxyflurane

patients who received ticagrelor followed with inhaled methoxyflurane due to unstable angina

DRUG

Ticagrelor followed with Morphine

patients who received ticagrelor followed with intravenous morphine due to unstable angina

DRUG

Ticagrelor alone

patients who received ticagrelor without any analgesia due to unstable angina

Trial Locations (1)

85-094

Cardiology Department, Dr. A. Jurasz University Hospital, Bydgoszcz

All Listed Sponsors
lead

Collegium Medicum w Bydgoszczy

OTHER

NCT04442919 - Influence of METHoxyflurane on ANtiplatelet Effect of Ticagrelor in Patients With Unstable Angina Pectoris | Biotech Hunter | Biotech Hunter